Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-12-04Clinical Trial Update: A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of KYN-5356 in Healthy Subjects Aged 18 to 55 Years [Phase 1]
A Phase 1 study evaluating the safety, tolerability, and pharmacokinetics of KYN-5356 in healthy adults aged 18 to 55 has completed.
-
FDA approval · 2024-12-03FDA Approved: LURASIDONE HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for lurasidone hydrochloride from Amneal Pharmaceuticals LLC, supporting the generic product's conti…
-
FDA approval · 2024-11-26FDA Approved: OLANZAPINE — Supplemental Application (Ascend Laboratories, LLC)
FDA approved a supplemental application for Ascend Laboratories, LLC to market a generic olanzapine product under an ANDA. This marks the cl…
-
CLINICAL_TRIALS trial_result · 2024-11-25Clinical Trial Update: A Clinical Study to Investigate the Effect of an Investigational Drug as an Added Medication to an Antipsychotic, in Adults With Schizophrenia, as Measured Positron Emission Tomography (PET) Imaging [Phase 1]
Phase 1 study evaluating an investigational drug added to an antipsychotic in adults with schizophrenia, using PET imaging to assess effects…
-
CLINICAL_TRIALS research · 2024-11-25Clinical Trial Update: Establishing a Clinical Database and Biobank for Schizophrenia：A Cohort Study
This study aims to establish a centralized clinical database and biobank for schizophrenia. It will enroll participants to collect clinical …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-11-22Clinical Trial Update: Evaluating Pharmacogenomics-Based Pharmacotherapy in Real-World Settings for Schizophrenia
This clinical trial update describes a study evaluating pharmacogenomics-guided pharmacotherapy for schizophrenia in real-world settings, wh…
-
CLINICAL_TRIALS trial_result · 2024-11-21Clinical Trial Update: Effects of Music Beat on Motor Function in Individuals At Risk for Psychotic Onset and Schizophrenia Patients [NA]
A completed clinical trial evaluated the effects of music beat on motor function in individuals at risk for psychotic onset and in schizophr…
-
CLINICAL_TRIALS trial_result · 2024-11-19Clinical Trial Update: Rituximab Treatment for Psychosis And/or Obsessive Compulsive Disorder with Probable Immune System Involvement [Phase 2]
Phase 2 clinical trial update for rituximab in people with psychosis and obsessive-compulsive disorder with suspected immune involvement; re…
-
CLINICAL_TRIALS research · 2024-11-19Clinical Trial Update: Brain Circuitry Therapeutics for Schizophrenia [NA]
Clinical trial update indicating that a schizophrenia-focused brain circuitry therapy is currently recruiting; no results reported.
-
CLINICAL_TRIALS research · 2024-11-19Clinical Trial Update: Effects of Lurasidone on Left Ventricle Systolic Functions
A clinical trial is evaluating how lurasidone affects left ventricular systolic function in patients with schizophrenia or bipolar disorder;…
-
FDA approval · 2024-11-18FDA Approved: QUETIAPINE FUMARATE — Supplemental Application (Macleods Pharmaceuticals Limited)
The FDA approved a supplemental application for Quetiapine fumarate by Macleods Pharmaceuticals Limited, enabling a generic version of the a…
-
FDA approval · 2024-11-18FDA Approved: CHLORPROMAZINE HYDROCHLORIDE — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved chlorpromazine hydrochloride as a generic product under an original ANDA for Camber Pharmaceuticals.
-
CLINICAL_TRIALS research · 2024-11-18Clinical Trial Update: Face Your Fears: Cognitive Behavioural Virtual Reality Therapy for "Paranoia". [NA]
This entry reports the completion of a clinical trial evaluating Cognitive Behavioural Virtual Reality Therapy for paranoia in schizophrenia…
-
CLINICAL_TRIALS trial_result · 2024-11-15Clinical Trial Update: Effects of tES Combined With Retrieval Practice on Semantic Memory in Patients With Schizophrenia [NA]
Completed clinical study evaluating transcranial electrical stimulation combined with retrieval practice for improving semantic memory in pa…
-
CLINICAL_TRIALS trial_result · 2024-11-13Clinical Trial Update: Service User and Staff Views on Digital Remote Monitoring for Psychosis
A completed clinical trial update reporting on the views of service users and staff regarding digital remote monitoring for psychosis.
-
FDA approval · 2024-11-12FDA Approved: ARIPIPRAZOLE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for a generic form of aripiprazole from Aurobindo Pharma Limited.
-
CLINICAL_TRIALS withdrawal · 2024-11-12Clinical Trial Update: Study to Evaluate the Efficacy, Safety, and Tolerability of Valbenazine as an Adjunctive Treatment for Schizophrenia [Phase 3]
A Phase 3 trial evaluating valbenazine as an adjunctive treatment for schizophrenia has been terminated.
-
CLINICAL_TRIALS research · 2024-11-12Clinical Trial Update: M1 Schizophrenia PET Study [Phase 1]
A Phase 1 PET imaging study (M1) at Yale University investigating schizophrenia and schizoaffective disorder has completed.
-
CLINICAL_TRIALS trial_result · 2024-11-08Clinical Trial Update: Mobile-Assisted Cognitive Behavior Therapy for Negative Symptoms in Schizophrenia [NA]
This update reports a completed clinical trial evaluating a mobile-assisted cognitive behavioral therapy intervention for negative symptoms …
-
CLINICAL_TRIALS trial_result · 2024-11-08Clinical Trial Update: Mobile CBT for Negative Symptoms [NA]
A completed clinical trial evaluating mobile cognitive-behavioral therapy for negative symptoms in schizophrenia and schizoaffective disorde…
-
CLINICAL_TRIALS research · 2024-11-07Clinical Trial Update: Voice-Based Biomarkers: a Novel Approach to Monitoring and Predicting Schizophrenia Relapses [NA]
This clinical trial investigates voice-based biomarkers as a novel approach to monitor and predict relapses in schizophrenia. It is currentl…
-
CLINICAL_TRIALS trial_result · 2024-11-07Clinical Trial Update: Lumateperone for the Prevention of Relapse in Patients With Schizophrenia [Phase 3]
A Phase 3 trial evaluating lumateperone for relapse prevention in schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2024-10-31Clinical Trial Update: Comparison of Remimazolam and Etomidate As Induction Agents for Electroconvulsive Treatment [Phase 4]
Phase 4 trial comparing remimazolam and etomidate as induction agents for electroconvulsive therapy has completed, potentially informing ane…
-
CLINICAL_TRIALS trial_result · 2024-10-31Clinical Trial Update: A Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASP4345 in Patients With Schizophrenia [Phase 1]
A Phase 1 study evaluating the safety, tolerability, pharmacokinetics and pharmacodynamics of ASP4345 in schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2024-10-31Clinical Trial Update: A Study to Assess the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of ASP6981 in Subjects With Schizophrenia [Phase 1]
This clinical trial update summarizes a Phase 1 study of ASP6981 in schizophrenia, evaluating safety, tolerability, pharmacodynamics, and ph…